The global chronic cough market is expected to reach US$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimated to grow at a CAGR of 7.8% from 2020 to 2027. The market growth is attributed to the key factors such as increasing rising incidences of chronic cough and growing product developments to treat chronic cough. On the other hand, product recall is the major factor, which is likely to affect the market growth negatively during the forecast period.
The developments in the pharmaceutical and biopharmaceutical industry for the drugs that can treat chronic cough are likely to lead the market growth.Additionally, there is a rise in the numbers of pharmaceutical companies across the world.
Several startups across the globe are involved in the product development for chronic cough. For instance, in May 2020, BELLUS Health Inc., a biopharmaceutical company, has developed novel therapeutics for the chronic cough and other hypersensitization-related disorders. The company is constantly engaged in product development and has recently conducted a virtual key opinion leader (KOL) meeting to discuss the developments regarding chronic cough on 27 May 2020. Specifically, the meeting covered the developmental aspects regarding phase 2 RELIEF trial of BLU-5937 in chronic refractory cough. The company is looking forward to releasing data of clinical trials for RELIEF in June or July 2020.
The universities are engaged in research work for the development of new drugs to cure chronic cough.For instance, in February 2020, the results of two clinical trials phases for a new drug, Gefapixant were releases.
The researchers at the University of Manchester developed Gefapixant. The pharmaceutical market leader Merck & Co., Inc. (MSD) funded the clinical trials, in which the results showed that a dose of 7.5 mg reduced the cough by 52%, 20mg by 52%, and 50mg by 67% from baseline. The drug targets P2X3 receptors in the nerves that control coughing. Therefore, the developments by the pharmaceutical companies to treat chronic cough are likely to support the market growth during the forecast period. The global chronic cough market is segmented by drug class, route of administration, and distribution channel.Based on drug class, the market is segmented into antihistamines, corticosteroids, decongestants, combination drug, antibiotics, acid blockers, and other drug class.
The combination drug segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR during the forecast period.Based on route of administration, the chronic cough market has been segmented into oral, injections, inhalation, and other route of administration.
The oral segment held the largest share of the market in 2019; whereas, the inhalation segment is estimated to register the highest CAGR during the forecast period.Based on distribution channel, the chronic cough market has been segmented into hospital pharmacy, online pharmacy, and retail pharmacy.
The hospital pharmacy segment held largest market share in 2019. However, online pharmacy is expected to grow at a fastest CAGR during forecast period.
The American College of Chest Physicians, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Dubai Health Authority, European Respiratory Society, and Japanese Respiratory Society are among the essential secondary sources refereed to while preparing this report.
Our reports have been used by over 10K customers, including:
The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019; it is expected to grow at a CAGR of 12.6% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However,...
The mail order pharmacy market was valued at US$ 48,977 million in 2019 and is projected to reach US$ 166,384.85 million by 2027; it is expected to grow at a CAGR of 16.5% from 2020 to 2027. Increasing incidences of chronic diseases and increasing adoption of mail order pharmacy in healthcare sector are among the major factors fueling...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Online Pharmacy Market Report
The global online pharmacy market by revenue is expected to grow at a CAGR of over 20% during the period 2019–2025.
The global online pharmacy market size is likely to cross revenues of over $131 billion...
The North American Chronic Cough market is projected to reach US$ 3,944.89 million by 2027 from US$ 2,118.42 million in 2019; it is estimated to grow with a CAGR of 8.1% from 2020 to 2027. The growth of the chronic cough market is primarily attributed to rising incidences of chronic cough, growing product developments to treat chronic cough....
Advancement in filling machine technology and growth in the manufacturing of lyophilized drugs are projected to drive the dual chamber syringe (DCS) filling machine market. The global installed base of dual chamber syringe (DCS) filling machine market size is projected to grow from USD 258 million in 2020 to USD 381 million by 2025, at...
The Asia Pacific chronic cough market is projected to reach US$ 2,155.25 millionby2027 from US$1,136.66 million in 2019; it is estimated to grow with a CAGR of 8.4%from 2020 to 2027. The growth of the Asia Pacific chronic cough market is primarily attributed to the rising incidences of chronic cough among population and growing product...
The Europe Chronic Cough market is projected to reach US$ 2,881.55 million by 2027 from US$ 1,647.94 million in 2019; it is estimated to grow with a CAGR of 7.3% from 2020 to 2027. The growth of the chronic cough market is primarily attributed to rising incidences of chronic cough, growing product developments to treat chronic cough. More...
The global pharmacy management system market is expected to reach US$ 13,985.27 Mn in 2027 from US$ 5,724.82 Mn in 2019. The market is estimated to grow with a CAGR of 11.9% from 2019-2027. The factors driving the growth of pharmacy management system include growing healthcare IT industry and increasing number of pharmacies worldwide.Also,...
The healthcare distribution market is projected to grow at a CAGR of 6.5% during the forecast period of 2019 to 2024 The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024 from USD 765.4 billion in 2019, at a CAGR of 6.5%. The growth of this market is primarily driven by the rising incidence...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.